SCHEMBL755205

SCHEMBL755205

O=P(O)(OCCO)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.48
CFTR P13569 1/20 0.47
CA2 P00918 3/20 0.46
CA4 P22748 2/20 0.46
CA5A P35218 2/20 0.46
DGAT1 O75907 1/20 0.44
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
ALDH1A1 P00352 3/20 0.42
TSHR P16473 3/20 0.42
RECQL P46063 1/20 0.42
LMNA P02545 1/20 0.41
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA5B Q9Y2D0 1/20 0.40
ALOX15 P16050 1/20 0.39
USP2 O75604 1/20 0.39
MCHR1 Q99705 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15732278 0.90 CA2 (0.52) GAACFTRCA2CA4CA5A
SCHEMBL17489007 0.84 MEN1 (0.55) CFTRCA2CA4CA5ADGAT1
Ethylene Glycol SCHEMBL20377406 0.84 DGAT1 (0.43) GAACFTRCA2CA4CA5A
SCHEMBL6888602 0.83 CA2 (0.50) GAACFTRCA2CA4CA5A
Ammonia Solution, Strong SCHEMBL11707544 0.82 MEN1 (0.50) GAACFTRCA2CA4CA5A
SCHEMBL343472 0.82 MEN1 (0.67) CFTRCA2CA4CA5ADGAT1
SCHEMBL26133027 0.82 CA2 (0.46) GAACFTRCA2CA4CA5A
SCHEMBL755204 0.82 GAA (0.50) GAACFTRCA2CA4CA5A
SCHEMBL28318108 0.82 MEN1 (0.66) GAACFTRCA2CA4CA5A
SCHEMBL16335471 0.81 NPSR1 (0.46) CFTRCA2CA4CA5ADGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8476372-B2 Polyester fiber and method for its production, and tire cord, tire, belt-reinforcing fiber material and belt comprising the polyester fiber TEIJIN FIBERS LIMITED (JP) 2013-07-02 US disclosed
US-20130071804-A1 Adhesive for Teeth-Straightening Members TOKUYAMA DENTAL CORPORATION (JP) 2013-03-21 US disclosed
EP-2258891-B1 POLYETHYLENE NAPHTHALATE FIBER AND PROCESS FOR PRODUCING THE POLYETHYLENE NAPHTHALATE FIBER TEIJIN FIBERS LTD (JP) 2012-12-12 EP disclosed
EP-2253747-B1 POLYETHYLENE NAPHTHALATE FIBER AND PROCESS FOR PRODUCING THE POLYETHYLENE NAPHTHALATE FIBER TEIJIN FIBERS LTD (JP) 2012-11-07 EP disclosed
EP-2261403-B1 POLYESTER FIBER, PROCESS FOR PRODUCING THE POLYESTER FIBER, AND TIRE CODE, TIRE, FIBER MATERIAL FOR REINFORCING BELT AND BELT EACH COMPRISING THE POLYESTER FIBER TEIJIN FIBERS LTD (JP) 2012-03-21 EP disclosed
US-20110017378-A1 POLYESTER FIBER AND METHOD FOR ITS PRODUCTION, AND TIRE CORD, TIRE, BELT-REINFORCING FIBER MATERIAL AND BELT COMPRISING THE POLYESTER FIBER TEIJIN FIBERS LIMITED (JP) 2011-01-27 US disclosed
EP-2261403-A1 POLYESTER FIBER, PROCESS FOR PRODUCING THE POLYESTER FIBER, AND TIRE CODE, TIRE, FIBER MATERIAL FOR REINFORCING BELT AND BELT EACH COMPRISING THE POLYESTER FIBER Teijin Fibers Limited (JP) 2010-12-15 EP disclosed
EP-2258891-A1 POLYETHYLENE NAPHTHALATE FIBER AND PROCESS FOR PRODUCING THE POLYETHYLENE NAPHTHALATE FIBER Teijin Fibers Limited (JP) 2010-12-08 EP disclosed
EP-2253747-A1 POLYETHYLENE NAPHTHALATE FIBER AND PROCESS FOR PRODUCING THE POLYETHYLENE NAPHTHALATE FIBER Teijin Fibers Limited (JP) 2010-11-24 EP disclosed
US-20100184882-A1 ADHESIVE FOR TEETH-STRAIGHTENING MEMBERS NIHON UNIVERSITY (JP) 2010-07-22 US disclosed
US-7649015-B2 Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds GILEAD SCIENCES, INC. (US) 2010-01-19 US disclosed
US-20070010489-A1 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds GILEAD SCIENCES, INC. 2007-01-11 US disclosed
EP-1711617-A1 METHOD AND COMPOSITIONS FOR IDENTIFYING ANTI-HIV THERAPEUTICS COMPOUNDS GILEAD SCIENCES, INC. (US) 2006-10-18 EP disclosed
WO-2005064008-A9 METHOD AND COMPOSITIONS FOR IDENTIFYING ANTI-HIV THERAPEUTIC COMPOUNDS GILEAD SCIENCES INC (US) 2006-09-28 WO disclosed
US-20050239054-A1 Method and compositions for identifying anti-HIV therapeutic compounds GILEAD SCIENCES. INC. 2005-10-27 US disclosed
US-20050209197-A1 Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds GILEAD SCIENCES, INC. 2005-09-22 US disclosed
WO-2005064008-A1 METHOD AND COMPOSITIONS FOR IDENTIFYING ANTI-HIV THERAPEUTIC COMPOUNDS GILEAD SCIENCES, INC. (US) 2005-07-14 WO disclosed
EP-1509537-A2 CELLULAR ACCUMULATION OF PHOSPHONATE ANALOGS OF HIV PROTEASE INHIBITOR COMPOUNDS AND THE COMPOUNDS AS SUCH GILEAD SCIENCES, INC. (US) 2005-03-02 EP disclosed
WO-2003090690-A2 CELLULAR ACCUMULATION OF PHOSPHONATE ANALOGS OF HIV PROTEASE INHIBITOR COMPOUNDS AND THE COMPOUNDS AS SUCH GILEAD SCIENCES, INC. (US) 2003-11-06 WO disclosed
EP-0731124-A1 FLAME RETARDANT POLYESTER KANEBO, LTD. (JP) 1996-09-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050209197-A1 Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds PPA1, PPME1, PNP GAA 39/4885CFTR 3330/4885CA2 3935/4885
US-20050239054-A1 Method and compositions for identifying anti-HIV therapeutic compounds CES1, PNP, PGLS GAA 24/4885CFTR 4411/4885CA2 3487/4885
US-20100184882-A1 ADHESIVE FOR TEETH-STRAIGHTENING MEMBERS ICAM1, TLN1, COIL GAA 3617/4885CFTR 4798/4885CA2 2999/4885
US-20070010489-A1 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds PPA1, PNP, PPME1 GAA 31/4885CFTR 3291/4885CA2 3915/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.